General Information of Disease (ID: DISJUN66)

Disease Name Paraneoplastic syndrome
Synonyms paraneoplastic syndrome
Definition
A classification for rare disorders of diverse organ systems (endocrine, neuromuscular, gastrointestinal, renal, dermatologic, rheumatologic, hematologic) that are affected by substances secreted by a distant neoplasm but not by the action of the neoplasm itself metastasizing to that organ or tissue. Less than 1 % of neoplasms are associated with these syndromes. An immune-mediated response to neoplasm-elaborated proteins may be the cause of these syndromes. Additionally, their manifestation may signal the presence of an occult neoplasm, potentially at an earlier stage of disease thereby leading to a better clinical outcome. Constitutional signs may include fever, night sweats, anorexia and cachexia. Clinical course is usually progressive. Prognosis is variable depending on the effective treatment of the underlying neoplasm.
Disease Hierarchy
DIS6SVEE: Syndromic disease
:
DISJUN66: Paraneoplastic syndrome
Disease Identifiers
MONDO ID
MONDO_0021073
MESH ID
D010257
UMLS CUI
C0030472
MedGen ID
45320
SNOMED CT ID
49783001

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 2 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
EPO TTQG4NR Limited Biomarker [1]
FGF23 TT2IZ4K moderate Biomarker [2]
------------------------------------------------------------------------------------
This Disease Is Related to 4 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
DPYSL5 OT6F9T6F Limited Biomarker [3]
PHEX OTG7N3J7 Limited Altered Expression [4]
PTHLH OTI1JF13 moderate Biomarker [5]
CDR2 OTD3ZJST Strong Biomarker [6]
------------------------------------------------------------------------------------

References

1 Serum erythropoietin level in anemic cancer patients.Med Oncol. 2000 Feb;17(1):29-34. doi: 10.1007/BF02826213.
2 Tumor-induced osteomalacia - Current imaging modalities and a systematic approach for tumor localization.Clin Imaging. 2019 Jul-Aug;56:114-123. doi: 10.1016/j.clinimag.2019.04.007. Epub 2019 Apr 17.
3 CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis.J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):241-2. doi: 10.1136/jnnp.2008.149336.
4 Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity.J Biol Chem. 1998 May 29;273(22):13729-37. doi: 10.1074/jbc.273.22.13729.
5 Parathyroid hormone-related protein: an update.J Clin Endocrinol Metab. 2012 Sep;97(9):2947-56. doi: 10.1210/jc.2012-2142. Epub 2012 Jun 28.
6 Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.Oncogene. 2009 Sep 17;28(37):3274-85. doi: 10.1038/onc.2009.186. Epub 2009 Jul 6.